桑尼森迪赴港IPO：IP短约、存货高企 靠爆款催熟的业绩难撑估值泡沫？

Core Viewpoint - Sunny Sandi, an IP toy company, has submitted its prospectus to the Hong Kong Stock Exchange for a main board listing, with Goldman Sachs and CICC as joint sponsors [1][14] Financial Performance - For the first three quarters of 2023-2025, Sunny Sandi reported revenues of 107 million yuan, 245 million yuan, and 386 million yuan, representing year-on-year growth of 129.0% and 134.6% [1][14] - The company recorded net profits of -19.92 million yuan, -0.505 million yuan, and 51.96 million yuan, with an adjusted net profit margin of approximately 13.7% as of September 30, 2025 [1][14] Business Model and Revenue Sources - The main business of Sunny Sandi is not trendy toys but OEM production of IP toys for overseas food and beverage companies, with IP toy-related revenue accounting for 72.0% and 51.4% of total revenue in 2023-2024 [2][15] - Revenue from collaborations with well-known IPs surged nearly fourfold in the first three quarters of 2025, making up 78.3% of total revenue [2][15] Market Position and IP Strategy - Unlike competitors targeting major IPs like Ultraman and Disney, Sunny Sandi capitalized on the rise of domestic animated films, achieving significant box office success with "Nezha" and "Wang Wang Mountain Little Monster" [3][16] - The company generated 196 million yuan from domestic cultural IPs in the first three quarters of 2025, contributing 50.8% to total revenue [3][16] Inventory and Cost Management - As of September 30, 2025, Sunny Sandi's inventory value reached 126 million yuan, accounting for 59.9% of current assets, with a significant portion of inventory aging under three months [8][23] - The company's inventory turnover days exceeded 100 days, compared to 40-50 days for competitors like TOP TOY and Jin Tian Animation [8][23] Investment and Valuation - Sunny Sandi's valuation has increased significantly, with recent investments from Hillhouse Capital and Aurora Management Ventures raising its estimated value to 4 billion yuan [9][26] - The company's price-to-sales ratio is approximately 10.36, higher than competitors, while its price-to-earnings ratio stands at 77, indicating potential overvaluation [9][26]